CVMM International Speaker Series
6 May, 3pm-4pm
The Cardiac, Vascular & Metabolic Medicine Theme presents the second event in its series of faculty-wide lectures by renowned international speakers. Our visiting speaker is Prof. James Ware of the Imperial College London, speaking on the topic of polygenic determinants of monogenic cardiovascular disease.
Join in person or online:
Garvan Auditorium
384 Victoria St
Darlinghurst NSW
This event is supported by the UNSW Cardiac, Vascular and Metabolic Medicine (CVMM) Theme and organised by the CVMM International Speaker Fellowship recipient, A/Prof Jodie Ingles, Program Director, Genomics and Inherited Disease (GID) and Lab Head, Clinical Genomics, Garvan Institute of Medical Research.
Registration is free and open to all, however places are limited.
About the speaker
James Ware is a Professor of Cardiovascular and Genomic Medicine at the National Heart & Lung Institute, Imperial College London; an MRC Investigator at the London Laboratory of Medical Sciences; honorary Consultant Cardiologist at Royal Brompton Hospital and Hammersmith Hospital; and a Visiting Scientist at the Broad Institute of MIT & Harvard. He graduated from the University of Cambridge, trained clinically in London & Geneva, and pursued research training at Imperial College London, Harvard Medical School, and the Broad Institute before starting a research group at Imperial. James' research aims to understand the impact of genetic variation on the heart and circulation and to use genome information to improve patient care. Working with collaborators in the UK and internationally, his team identifies new genes and pathways underlying inherited cardiovascular conditions, develops tools to discriminate between pathogenic and benign genetic variation, and evaluates genetic stratification for precision medicine. James is also the Director of the national MRC Cardiovascular Rare Disease Node and colead of the Cardiovascular Research Programme for Genomics England (GECIP). Clinical interests include the management of Inherited Cardiac Conditions, the prevention of sudden cardiac arrest, and the broader application of genetics and genomics to healthcare.